North America And Europe Phototherapy Treatment Market Analysis

The opportunity analysis covered to understand the North America and Europe phototherapy treatment market for acne and psoriasis, makes this new publication an exclusive one. After a thorough study of the market, our expert team of analysts in the healthcare domain went the extra mile to offer in-depth insights into the market. While studying the market the first important feature we have observed is that this market is likely to witness moderate growth during the 10 year projected period. After a detailed study of the future scenario of the overall market, it was easy for our analysts to identify the macroeconomic factors such as the economic burden of skin diseases and societal habits influencing the phototherapy treatment market for acne and psoriasis in North America and Europe. The report titled “Phototherapy Treatment Market for Acne and Psoriasis: North America and Europe Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027” provides detailed information on how the lack of robust clinical evidence on various disease conditions is limiting the growth of the phototherapy treatment market for acne and psoriasis in the regions of North America and Europe.

One astonishing fact we have come across while inspecting this market is that even in the most developed regions such as North America and Europe, not much research has been done on the other light therapies used in the treatment of acne and psoriasis conditions except blue light and UVB therapy. On the other hand while covering the disease epidemiology we have observed that prevalent cases of acne and psoriasis were remarkable in both the regions especially Europe in 2015.

Is the home-based phototherapy system a solution to limit the rising incidents of the disease?

Usually, phototherapy is an office based treatment procedure. However, lack of sufficient phototherapy units and the majority of phototherapy centres being located in urban areas are forcing patients to choose alternative treatments for their dermatological conditions. An increasing adoption of home-based phototherapy systems is creating huge opportunities for manufacturers. Home based phototherapy reduces patient hassles like transportation issues and the long waiting time in clinics, among others. In addition to this, it also reduces the direct and indirect medical costs of patients.

Our unique analysis of the classification of markets in various segments

According to our analysis, North America represents the most lucrative market, followed by Western Europe and Eastern Europe.

• Hospitals end user segment dominates the global market; however, home care settings are becoming the choice of service for patients
• Blue light therapy is gaining more traction in phototherapy owing to its benefits in treating acne
• Plaque psoriasis sub-segment dominates the market in the psoriasis disease segment due to rise in psoriasis patient population

International monoclonal antibody conference reports – our key source while researching this market

While inspecting the North America and Europe phototherapy treatment market for acne and psoriasis in detail, we have referred to the annual reports, publications, and presentations of product providers. Our analysts have also considered key winning strategies followed by phototherapy treatment market for acne and psoriasis product manufacturers. We have carried out systematic and exhaustive secondary research to analyse the required data points to arrive at the overall market numbers. Detailed questionnaires have been developed for each node in the value chain to extract the required market information through primary research interviews. Data acquired through research is represented using charts, infographics, presentation of key findings by region and providing strategic recommendations and actionable insights for critical decision making.

North America and Europe Phototherapy Treatment for Acne and Psoriasis Market – Taxonomy

By Disease Type	By Phototherapy Type	By End User	By Region
Psoriasis Guttate Psoriasis Inverse Psoriasis Pustular Psoriasis Erythrodermic Psoriasis Plaque Psoriasis Acne Acne Vulgaris Acne Conglobata Acne Fulminans Gram-Negative Folliculitis Acne Rosacea Pyoderma Faciale	Blue Light Phototherapy Red Light Phototherapy Intense Pulsed Light (IPL) Phototherapy Narrowband UVB Phototherapy Psoralens+Ultravioletlight A (PUVA) Phototherapy	Hospitals Dermatology Clinics/Skin Care Centres Wellness Centres Home Care Settings	North America Western Europe Eastern Europe

North America And Europe Phototherapy Treatment Market Reports - Table of Contents

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

2.3. Phototherapy Treatment Market Overview

3. Medical Bionic Implants & Exoskeletons Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Pricing Assumptions

4. North America Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

4.5.1. Psoriasis

4.5.1.1. Guttate Psoriasis

4.5.1.2. Inverse Psoriasis

4.5.1.3. Pustular Psoriasis

4.5.1.4. Erythrodermic Psoriasis

4.5.1.5. Plaque Psoriasis

4.5.2. Acne

4.5.2.1. Acne Vulgaris

4.5.2.2. Acne Conglobata

4.5.2.3. Acne Fulminans

4.5.2.4. Gram-Negative Folliculitis

4.5.2.5. Acne Rosacea

4.5.2.6. Pyoderma Faciale

4.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

4.6.1. Psoriasis

4.6.1.1. Guttate Psoriasis

4.6.1.2. Inverse Psoriasis

4.6.1.3. Pustular Psoriasis

4.6.1.4. Erythrodermic Psoriasis

4.6.1.5. Plaque Psoriasis

4.6.2. Acne

4.6.2.1. Acne Vulgaris

4.6.2.2. Acne Conglobata

4.6.2.3. Acne Fulminans

4.6.2.4. Gram-Negative Folliculitis

4.6.2.5. Acne Rosacea

4.6.2.6. Pyoderma Faciale

4.7. Historical Market Size (US$ Mn) Analysis By Phototherapy, 2012-2016

4.7.1. Blue Light Phototherapy

4.7.2. Red Light Phototherapy

4.7.3. Intense Pulsed Light (IPL) Phototherapy

4.7.4. Combination Treatment

4.7.5. Narrowband UVB Phototherapy

4.7.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

4.7.7. Others

4.8. Market Size (US$ Mn) Forecast By Phototherapy, 2017-2027

4.8.1. Blue Light Phototherapy

4.8.2. Red Light Phototherapy

4.8.3. Intense Pulsed Light (IPL) Phototherapy

4.8.4. Combination Treatment

4.8.5. Narrowband UVB Phototherapy

4.8.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

4.8.7. Others

4.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016

4.9.1. Hospitals

4.9.2. Dermatology Clinics/Skin Care Centers

4.9.3. Wellness Centers

4.9.4. Home Care Settings 

4.10.Market Size (US$ Mn) Forecast By End User, 2017-2027

4.10.1. Hospitals

4.10.2. Dermatology Clinics/Skin Care Centers

4.10.3. Wellness Centers

4.10.4. Home Care Settings

4.11.Market Attractiveness Analysis

4.11.1. By Country

4.11.2. By Disease Type

4.11.3. By Phototherapy

4.11.4. By End User

5. Western Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027 

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

5.3.1. Germany

5.3.2. United Kingdom

5.3.3. France

5.3.4. Italy

5.3.5. Spain

5.3.6. Nordics

5.3.7. BENELUX

5.3.8. Rest of Western Europe

5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

5.4.1. Germany

5.4.2. United Kingdom

5.4.3. France

5.4.4. Italy

5.4.5. Spain

5.4.6. Nordics

5.4.7. BENELUX

5.4.8. Rest of Western Europe

5.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

5.5.1. Psoriasis

5.5.1.1. Guttate Psoriasis

5.5.1.2. Inverse Psoriasis

5.5.1.3. Pustular Psoriasis

5.5.1.4. Erythrodermic Psoriasis

5.5.1.5. Plaque Psoriasis

5.5.2. Acne

5.5.2.1. Acne Vulgaris

5.5.2.2. Acne Conglobata

5.5.2.3. Acne Fulminans

5.5.2.4. Gram-Negative Folliculitis

5.5.2.5. Acne Rosacea

5.5.2.6. Pyoderma Faciale

5.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

5.6.1. Psoriasis

5.6.1.1. Guttate Psoriasis

5.6.1.2. Inverse Psoriasis

5.6.1.3. Pustular Psoriasis

5.6.1.4. Erythrodermic Psoriasis

5.6.1.5. Plaque Psoriasis

5.6.2. Acne

5.6.2.1. Acne Vulgaris

5.6.2.2. Acne Conglobata

5.6.2.3. Acne Fulminans

5.6.2.4. Gram-Negative Folliculitis

5.6.2.5. Acne Rosacea

5.6.2.6. Pyoderma Faciale

5.7. Historical Market Size (US$ Mn) Analysis By Phototherapy, 2012-2016

5.7.1. Blue Light Phototherapy

5.7.2. Red Light Phototherapy

5.7.3. Intense Pulsed Light (IPL) Phototherapy

5.7.4. Combination Treatment

5.7.5. Narrowband UVB Phototherapy

5.7.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

5.7.7. Others

5.8. Market Size (US$ Mn) Forecast By Phototherapy, 2017-2027

5.8.1. Blue Light Phototherapy

5.8.2. Red Light Phototherapy

5.8.3. Intense Pulsed Light (IPL) Phototherapy

5.8.4. Combination Treatment

5.8.5. Narrowband UVB Phototherapy

5.8.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

5.8.7. Others

5.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016

5.9.1. Hospitals

5.9.2. Dermatology Clinics/Skin Care Centers

5.9.3. Wellness Centers

5.9.4. Home Care Settings 

5.10.Market Size (US$ Mn) Forecast By End User, 2017-2027

5.10.1. Hospitals

5.10.2. Dermatology Clinics/Skin Care Centers

5.10.3. Wellness Centers

5.10.4. Home Care Settings

5.11.Market Attractiveness Analysis

5.11.1. By Country

5.11.2. By Disease Type

5.11.3. By Phototherapy

5.11.4. By End User

6. Eastern Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

6.3.1. Russia

6.3.2. Poland

6.3.3. Rest of Eastern Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

6.4.1. Russia

6.4.2. Poland

6.4.3. Rest of Eastern Europe

6.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

6.5.1. Psoriasis

6.5.1.1. Guttate Psoriasis

6.5.1.2. Inverse Psoriasis

6.5.1.3. Pustular Psoriasis

6.5.1.4. Erythrodermic Psoriasis

6.5.1.5. Plaque Psoriasis

6.5.2. Acne

6.5.2.1. Acne Vulgaris

6.5.2.2. Acne Conglobata

6.5.2.3. Acne Fulminans

6.5.2.4. Gram-Negative Folliculitis

6.5.2.5. Acne Rosacea

6.5.2.6. Pyoderma Faciale

6.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

6.6.1. Psoriasis

6.6.1.1. Guttate Psoriasis

6.6.1.2. Inverse Psoriasis

6.6.1.3. Pustular Psoriasis

6.6.1.4. Erythrodermic Psoriasis

6.6.1.5. Plaque Psoriasis

6.6.2. Acne

6.6.2.1. Acne Vulgaris

6.6.2.2. Acne Conglobata

6.6.2.3. Acne Fulminans

6.6.2.4. Gram-Negative Folliculitis

6.6.2.5. Acne Rosacea

6.6.2.6. Pyoderma Faciale

6.7. Historical Market Size (US$ Mn) Analysis By Phototherapy, 2012-2016

6.7.1. Blue Light Phototherapy

6.7.2. Red Light Phototherapy

6.7.3. Intense Pulsed Light (IPL) Phototherapy

6.7.4. Combination Treatment

6.7.5. Narrowband UVB Phototherapy

6.7.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

6.7.7. Others

6.8. Market Size (US$ Mn) Forecast By Phototherapy, 2017-2027

6.8.1. Blue Light Phototherapy

6.8.2. Red Light Phototherapy

6.8.3. Intense Pulsed Light (IPL) Phototherapy

6.8.4. Combination Treatment

6.8.5. Narrowband UVB Phototherapy

6.8.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

6.8.7. Others

6.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016

6.9.1. Hospitals

6.9.2. Dermatology Clinics/Skin Care Centers

6.9.3. Wellness Centers

6.9.4. Home Care Settings 

6.10.Market Size (US$ Mn) Forecast By End User, 2017-2027

6.10.1. Hospitals

6.10.2. Dermatology Clinics/Skin Care Centers

6.10.3. Wellness Centers

6.10.4. Home Care Settings

6.11.Market Attractiveness Analysis

6.11.1. By Country

6.11.2. By Disease Type

6.11.3. By Phototherapy

6.11.4. By End User

7. Forecast Factors: Relevance and Impact

8. Forecast Assumptions

9. Competition Landscape

9.1. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

9.1.1. Lifespan

9.1.2. UC Irvine Health

9.1.3. Buffalo Medical Group

9.1.4. Blackrock Clinic Limited

9.1.5. The Private Phototherapy Clinic Ltd

9.1.6. National Skin Centre

9.1.7. Massachusetts General Hospital

10. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By Region

10.1.Historical Market Size (US$ Mn) Analysis By Region, 2012-2016

10.1.1. North America

10.1.2. Western Europe

10.1.3. Eastern Europe

10.2.Market Size (US$ Mn) Forecast By Region, 2017-2027

10.2.1. North America

10.2.2. Western Europe

10.2.3. Eastern Europe

10.3.Market Attractiveness Analysis By Region

11. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By Disease

11.1.Introduction/Key Finding

11.2.Historical Market Size (US$ Mn) Analysis By Disease, 2012-2016

11.2.1. Psoriasis

11.2.1.1. Guttate Psoriasis

11.2.1.2. Inverse Psoriasis

11.2.1.3. Pustular Psoriasis

11.2.1.4. Erythrodermic Psoriasis

11.2.1.5. Plaque Psoriasis

11.2.2. Acne

11.2.2.1. Acne Vulgaris

11.2.2.2. Acne Conglobata

11.2.2.3. Acne Fulminans

11.2.2.4. Gram-Negative Folliculitis

11.2.2.5. Acne Rosacea

11.2.2.6. Pyoderma Faciale

11.3.Market Size (US$ Mn) Forecast By Disease, 2017-2027

11.3.1. Psoriasis

11.3.1.1. Guttate Psoriasis

11.3.1.2. Inverse Psoriasis

11.3.1.3. Pustular Psoriasis

11.3.1.4. Erythrodermic Psoriasis

11.3.1.5. Plaque Psoriasis

11.3.2. Acne

11.3.2.1. Acne Vulgaris

11.3.2.2. Acne Conglobata

11.3.2.3. Acne Fulminans

11.3.2.4. Gram-Negative Folliculitis

11.3.2.5. Acne Rosacea

11.3.2.6. Pyoderma Faciale

11.4.Market Attractiveness Analysis By Disease

12. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By Phototherapy 

12.1.Introduction/Key Finding

12.2.Historical Market Size (US$ Mn) Analysis By Mode, 2012-2016

12.2.1. Blue Light Phototherapy

12.2.2. Red Light Phototherapy

12.2.3. Intense Pulsed Light (IPL) Phototherapy

12.2.4. Combination Treatment

12.2.5. Narrowband UVB Phototherapy

12.2.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

12.2.7. Others

12.3.Market Size (US$ Mn) Forecast By Mode, 2017-2027

12.3.1. Blue Light Phototherapy

12.3.2. Red Light Phototherapy

12.3.3. Intense Pulsed Light (IPL) Phototherapy

12.3.4. Combination Treatment

12.3.5. Narrowband UVB Phototherapy

12.3.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

12.3.7. Others

12.4.Market Attractiveness Analysis By Phototherapy

13. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By End User 

13.1.Introduction/Key Finding

13.2.Historical Market Size (US$ Mn) Analysis By End User, 2012-2016

13.2.1. Hospitals

13.2.2. Dermatology Clinics/Skin Care Centers

13.2.3. Wellness Centers

13.2.4. Home Care Settings 

13.3.Market Size (US$ Mn) Forecast By End User, 2017-2027

13.3.1. Hospitals

13.3.2. Dermatology Clinics/Skin Care Centers

13.3.3. Wellness Centers

13.3.4. Home Care Settings 

13.4.Market Attractiveness Analysis By End User

14. Assumptions and Acronyms Used

15. Research Methodology